1-5 of 5
Fan Fan Hou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

866-P: Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis from the DAPA-CKD Study

FREDERIK PERSSON, PETER ROSSING, NIELS JONGS, GLENN M. CHERTOW, FAN FAN HOU, PRIYA VART, JOHN J. MCMURRAY, RICARDO CORREA-ROTTER, BERGUR STEFANSSON, ROBERT D. TOTO, ANNA MARIA LANGKILDE, DAVID C. WHEELER, HIDDO L. HEERSPINK, DAPA-CKD TRIAL COMMITTEES AND INVESTIGATORS
Journal: Diabetes
Diabetes 2022;71(Supplement_1):866-P
https://doi.org/10.2337/db22-866-P
Published: 01 June 2022
View article titled, 866-P: Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis from the DAPA-CKD Study
Meeting Abstracts

130-LB: Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease

PETER ROSSING, PRIYA VART, GLENN M. CHERTOW, FAN FAN HOU, NIELS JONGS, JOHN J. MCMURRAY, RICARDO CORREA-ROTTER, BERGUR STEFANSSON, ROBERT D. TOTO, ANNA MARIA LANGKILDE, DAVID C. WHEELER, HIDDO L. HEERSPINK, DAPA-CKD STUDY GROUP
Journal: Diabetes
Diabetes 2021;70(Supplement_1):130-LB
https://doi.org/10.2337/db21-130-LB
Published: 01 June 2021
View article titled, 130-LB: Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease
Meeting Abstracts

317-OR: Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial

FREDERIK PERSSON, PETER ROSSING, PRIYA VART, GLENN M. CHERTOW, FAN FAN HOU, JOHN J. MCMURRAY, RICARDO CORREA-ROTTER, HARPREET S. BAJAJ, BERGUR STEFANSSON, ROBERT D. TOTO, ANNA MARIA LANGKILDE, DAVID C. WHEELER, HIDDO L. HEERSPINK, DAPA-CKD STUDY GROUP
Journal: Diabetes
Diabetes 2021;70(Supplement_1):317-OR
https://doi.org/10.2337/db21-317-OR
Published: 01 June 2021
View article titled, 317-OR: Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial
Journal Articles

Erratum. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature. Diabetes 2019;68:

Ivan Hernandez-Diaz, Jiaqi Pan, Carlo Alberto Ricciardi, Xiaoyan Bai, Jianting Ke, Kathryn E. White, Maria Flaquer, Georgia E. Fouli, Fulye Argunhan, Anthea E. Hayward, Fan Fan Hou, Giovanni E. Mann, Robert Q. Miao, David A. Long, Luigi Gnudi
Journal: Diabetes
Diabetes 2020;69(2):267
https://doi.org/10.2337/db20-er02b
Published: 16 December 2019
View article titled, Erratum. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature. Diabetes 2019;68:
Open the PDF for Erratum. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature. Diabetes 2019;68: in another window
Journal Articles

Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature

Ivan Hernandez-Diaz, Jiaqi Pan, Carlo Alberto Ricciardi, Xiaoyan Bai, Jianting Ke, Kathryn E. White, Maria Flaquer, Georgia E. Fouli, Fulye Argunhan, Anthea E. Hayward, Fan Fan Hou, Giovanni E. Mann, Robert Q. Miao, David A. Long, Luigi Gnudi
Journal: Diabetes
Diabetes 2019;68(9):1841–1852
https://doi.org/10.2337/db19-0157
Published: 19 June 2019
View article titled, Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature
Open the PDF for Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature in another window
Includes: Supplementary data